Study identifies risk factors for cataracts in patients with diabetes mellitus

News
Article

Researchers set out to determine the most important systemic risk factors associated with cataract development in patients with DM.

Physician pricking finger with glucose meter on blue backdrop Image credit: ©KaterynaNovikova - adobe.stock.com

Image credit: AdobeStock/KaterynaNovikova

A research team from Romania identified a higher risk of cataract development in patients with diabetes mellitus (DM) who have had the disease for an extended period and who have had poor glycemic control in conjunction with systemic comorbidities,1 according to first author Adriana Ivanescu. She is from the Department of Second Internal Medicine Diabetes, Nutrition, Metabolic Diseases, and Systemic Rheumatology, “Victor Babes” University of Medicine and Pharmacy; and the Opticlass Ophthalmology Clinic, both in Timisoara, Romania.

Because DM is a well-known cause of visual loss, the researchers set out to determine the most important systemic risk factors associated with cataract development in patients with DM. “Considering the significant impact of cataracts on the quality of life of patients with diabetes, this study aimed to investigate the most important risk factors involved in cataract development to sensitize physicians to the importance of screening and early detection of cataracts and overall health among these patients,” the investigators stated.

A total of 319 patients with a diagnosis of DM were included in the study. The investigators analyzed the patient data retrieved from the medical charts that included the DM status, metabolic control, demographic and anthropometric indices, and generally associated comorbidities.

Data analysis

The authors reported studying the risk factors of hypertension, cardiovascular disease (CVD), chronic kidney disease (CKD), diabetic polyneuropathy (DPN), dyslipidemia, and hepatic steatosis, which were present in all the study patients.

The factors identified in the patients with cataract were the high prevalence rates of hypertension (67.6%), DPN (53.3%), and dyslipidemia (46.6%).

Among them, CKD (p < 0.001) and DPN (p = 0.019) were significant predictive factors for the probability of cataract development.

An ophthalmologic evaluation showed that diabetic retinopathy (DR) reached significance in the occurrence of cataracts. In addition, patient age and DM-related factors, such as disease duration (p < 0.001) and hemoglobin A1c values (p = 0.029), significantly increased the risk of cataracts. Smoking was self-reported by 24.8% of the patients, which also was related significantly to the occurrence of cataracts (p = 0.04).

The investigators concluded, “Our findings are consistent with those in the current literature, emphasizing that poor glycemic control and extended DM duration are the most critical risk factors for cataract development in patients with diabetes. Patients with DM are known to present with multiple associated pathologies such as hypertension, CVD, CKD, DPN, hepatic steatosis, and dyslipidemia. The present study identified CKD and DPN as the most influential comorbidities on cataract occurrence and development, whereas hepatic steatosis was linked to nuclear sclerotic cataracts. While maintaining optimal glycemic control remains a cornerstone strategy for preventing ophthalmological complications in patients with DM, early detection and management of all risk factors prevents the occurrence of vision-threatening cataracts and aids healthcare providers in obtaining better patient-related outcomes.”

Reference:
  1. Ivanescu A, Popescu S, Gaita L, et al. Risk factors for cataracts in patients with diabetes mellitus. J Clin Med. 2024;13:7005; https://doi.org/10.3390/jcm13237005

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
© 2025 MJH Life Sciences

All rights reserved.